NCT01659697
Unknown
Not Applicable
Diabetes Prevention in Patients Aged 25-55 From Ethiopian Origin With Prediabetes: Evaluation of Feasibility and Efficacy of Intensive or Less Intensive Lifestyle Intervention
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Ethnic Group
- Sponsor
- Meir Medical Center
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- occurence of diabetes
- Last Updated
- 13 years ago
Overview
Brief Summary
This study will evaluate the feasibility and efficacy of two interventions of lifestyle ( intensive and less intensive) to prevent diabetes in patients from Ethiopian origin, aged 25 to 55 years old with prediabetes living in Israel and insured by Clalit Health Services in the Central district, using resources existing in this Health Care system (HMO).
Investigators
Eligibility Criteria
Inclusion Criteria
- •prediabetes
- •age 25-55
- •ethiopian origin
Exclusion Criteria
- •age under 25 or above 55
- •non ethiopian origin
Outcomes
Primary Outcomes
occurence of diabetes
Time Frame: two years period
Patients included in the study will have a one year lifestyle intervention ( two arms: intensive, less intensive) and will be followed for two years for the occurence of diabetes
Secondary Outcomes
- change in Body Mass index and Physical activity(two years)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Lifestyle Intervention for Treatment of DiabetesType 2 DiabetesOverweightObesityNCT01806727Wake Forest University260
Completed
Not Applicable
Diabetes Prevention Strategies in Women With Gestational Diabetes Mellitus (GDM)Gestational DiabetesObesityNCT01344278Kaiser Permanente2,480
Completed
Not Applicable
Lifestyle Intervention for Senior DiabeticsDiabetes MellitusAgingOverweightNCT02348801Baylor College of Medicine100
Completed
Not Applicable
Development of a lifestyle intervention for diabetes prevention: SLIM from research to practiceinsulin insensitivityinsulin resistence10018424NL-OMON32800niversiteit Maastricht147
Completed
Not Applicable
Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational StudyDiabetes Mellitus, Type 2NCT00949286The George Institute8,494